Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you manage pleomorphic adenoma of minor salivary glands involving hypopharynx/larynx with positive surgical margin?
Would you offer adjuvant radiation? Dose/volume in postop setting?
Answer from: Radiation Oncologist at Academic Institution
Postop RT with carcinoma doses.
Sign in or Register to read more
16851
Related Questions
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
How would you manage a presumed radiation induced sarcoma of the head and neck?
How are you integrating the findings from KEYNOTE-689 into daily practice?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?